Lorviqua Lorlatinib Lorbrena

Lorviqua Lorlatinib Lorbrena Specification

Indication
ALK-positive metastatic non-small cell lung cancer (NSCLC)

Dosage Form
Tablet

Salt Composition
Lorlatinib

Feature
Prescription only, targeted ALK inhibitor

Ingredients
Lorlatinib

Application
Oral administration

Physical Color/Texture
Film-coated tablets

Storage Instructions
Store at 15C to 30C

Shelf Life
24 months

Tablet Shape
Round/Oval

Prescription Type
Prescription required

Brand Name
Lorviqua / Lorbrena

Administration Route
Oral

Color
Light yellow

Packaging
Blister pack

Strength
25 mg, 100 mg

Lorviqua Lorlatinib Lorbrena Trade Information

Minimum Order Quantity
1 Box

Supply Ability
5000 Boxes Per Month

Delivery Time
10 Days

About Lorviqua Lorlatinib Lorbrena

Jump on our Clearance selection of Lorviqua (Lorbrena) for a distinguished approach to ALK-positive metastatic non-small cell lung cancer (NSCLC) treatment. Available in sensational 25 mg and 100 mg strengths, these gorgeous light yellow, film-coated tablets offer outstanding efficacy as a targeted ALK inhibitor. Lorviqua is delivered in practical blister packs and requires a prescription for responsible use. Lorviqua/Lorbrena, with its round/oval shape, ensures reliable oral administration and is backed by a solid shelf life of 24 months. Exported and supplied across India by trustworthy traders and wholesalers.

Lorviqua Lorlatinib Lorbrena - Surface of Application & Key Advantages

Designed exclusively for oral administration, Lorviqua Lorlatinib Lorbrena demonstrates a gorgeous surface that's easy to swallow due to its film-coated finish. Its primary competitive advantage lies in its focus as a targeted ALK inhibitor, specifically combating ALK-positive metastatic NSCLC. The site of application pertains to systemic therapy, effectively distributing the medication throughout the body. Safe, efficient, and patient-friendly, Lorviqua stands out as an advanced prescription treatment for eligible individuals.

Efficient Delivery and Market Coverage for Lorviqua Lorlatinib Lorbrena

FOB Port options are readily available for international shipments of Lorviqua Lorlatinib Lorbrena, making global access seamless. The expenditure involved is transparent, ensuring a competitive trading experience. Once your order is confirmed, products are swiftly dispatched and typically delivered within agreed-upon delivery times. Serving the main domestic market of India, we ensure every wholesale, export, or supplier order is handled with care for distinguished customer satisfaction.

FAQ's of Lorviqua Lorlatinib Lorbrena:

Q: How is Lorviqua Lorlatinib Lorbrena administered?

A: Lorviqua Lorlatinib Lorbrena is designed for oral administration and should be taken as prescribed by a healthcare professional, with or without food.

Q: What is the benefit of using Lorviqua for ALK-positive NSCLC?

A: Lorviqua is a targeted ALK inhibitor, specifically formulated to block the ALK protein involved in the growth of certain lung cancers, offering a more distinguished and effective treatment option.

Q: When should Lorviqua be taken and what is the recommended dosage?

A: The dosage of Lorviqua (25 mg or 100 mg) and timing are determined by your physician based on individual health needs and treatment plans. Always follow the prescribed schedule.

Q: Where should Lorviqua Lorlatinib Lorbrena be stored?

A: Store Lorviqua Lorlatinib Lorbrena at temperatures between 15C and 30C in its original blister packaging to maintain its shelf life and effectiveness.

Q: What is the process to obtain Lorviqua Lorlatinib Lorbrena?

A: Since Lorviqua requires a prescription, consult your healthcare provider to determine eligibility. It is available for export, supply, and wholesale from authorized traders across India.